Aslan Pharmaceuticals

Related Content

Therapeutic: eblasakimab for atopic dermatitis

Aslan Pharmaceuticals makes appointments to scientific board

ASLAN and BioGenetics sign second commercialisation agreement

Therapeutics: anticancer agent: varlitinib

Aslan cuts costs by 50% to compensate for failed drug trial

Aslan announces shortened timeline to commercialisation for varlitinib

Aslan Pharmaceuticals receives IND approval by Singapore’s Health Sciences Authority

Aslan Pharmaceuticals announces new research collaboration

ASLAN Pharmaceuticals CEO Dr Carl Firth appointed to IAC singapore

ASLAN Pharmaceuticals commences first day of trading on Taipei Exchange

ASLAN Pharmaceuticals moves Taiwan office

Aslan wins Biosingapore Innovative Biomedical Company award

Aslan pharmaceuticals receives approval to list on Taipei exchange

JHL Biotech and ASLAN to partner on manufacturing services for ASLAN004

Bristol-Myers Squibb regains rights to Aslan cancer drug candidate in Asia